Search
for
Sort by
Research 121–150 of 1000+
- Volume imaging to interrogate cancer cell-tumor microenvironment interactions in space and time
- Amphiregulin in Fibrotic Diseases and Cancer
- Amphiregulin in Fibrotic Diseases and Cancer
- Advances of Microneedles for Cancer Diagnosis and Therapy
- An assessment of curcumin, curcumin spanlastics nanoparticles, and curcumin nanocrystals as possible drug delivery systems with antimicrobial, antioxidant, and antitumor activities
- Cold Atmospheric Plasma for Breast Cancer
- Epigenetics of Colorectal Cancer
- Chemotherapy-induced dermatological toxicity: frequencies and impact on quality of life in women’s cancers. Results of a prospective study
- Molecular Targeted Agents and Biologic Therapies for Non-small Cell Lung Cancer
- Canadian Expert Recommendations on Safety Overview and Toxicity Management Strategies for Sacituzumab Govitecan Based on Use in Metastatic Triple-Negative Breast Cancer
- ONCO-NK-TRANSITION-GM1: The Bridge Cancer Therapy Manufacturable by Current Pharmaceutical Industry — 60-80% Cure Rate — $50 per Dose A Complete Transitional Drug from Full N‑K GM Series to Current Pharma Capability
- EMT Factors and Metabolic Pathways in Cancer
- Drug repurposing: A novel strategy to target cancer stem cells and therapeutic resistance
- The ophthalmological complications of targeted agents in cancer therapy: what do we need to know as ophthalmologists?
- Transglutaminase 3: The Involvement in Epithelial Differentiation and Cancer
- Invasion and increased expression of S100A4 and CYR61 in mesenchymal transformed breast cancer cells is downregulated by GnRH
- A Transcriptome Sequencing Study on Genome-Wide Gene Expression Differences of Lung Cancer Cells Modulated by Fucoidan
- Protein degradation: expanding the toolbox to restrain cancer drug resistance
- Safety of Whole-Body Abrogation of the TRF1 Shelterin Protein in Wild-Type and Cancer-Prone Mouse Models
- Expression of Plectin-1 and Trichohyalin in Human Tongue Cancer Cells
- Role of the SOX family in cancer immune evasion: Emerging player and promising therapeutic opportunities
- Nano-Enabled CRISPR-Cas Gene Editing for Cancer Therapeutics
- Overcoming Curcumin's Limitations: Synthetic Derivatives in Diabetes and Cancer Management
- Sorting Out the Seeming Increase in Lung Cancer in Women Who Have Never Smoked
- RSPO1, a potent inducer of pancreatic β cell neogenesis
- Signal integrator function of CXXC5 in Cancer
- Evaluation of the Hemogram of Breast Cancer Patients Treated by Therapeutic Protocol Based on Immunohistochemical Analysis: A Retrospective Study
- Radiosensitization and Radioprotection by Curcumin in Glioblastoma and Other Cancers
- Molecular Mechanisms of Vitexin: An Update on Its Anti-Cancer Functions
- Perspective Chapter: Appraisal of Paclitaxel (Taxol) Pros and Cons in the Management of Cancer – Prospects in Drug Repurposing